BioMarin Pharmaceuticals
BMRN
NASDAQ
IPO1999
about BMRN
BioMarin Pharmaceuticals develops life-saving therapies for rare diseases, including treatments like Vimizim for Gaucher disease.
| type | open | high | low |
market cap |
volume |
|---|---|---|---|---|---|
| stock | $54.98 | $55.84 | $52.26 | $10.46B | 5.51M |
| eps |
price to earnings |
price to sales |
operating margin |
profit margin |
yield |
| +$1.25 | 16.30 | 12.76 | 33.55% | 29.14% | 0% |